Učitavanje...
Recent Advances in the Design and Development of Novel Negative Allosteric Modulators of mGlu(5)
[Image: see text] Negative allosteric modulators (NAMs) of metabotropic glutamate receptor subtype 5 (mGlu(5)) have remained attractive to researchers as potential therapies for a number of central nervous system related diseases, including anxiety, pain, gastresophageal reflux disease (GERD), addic...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Chemical Society
2011
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3172159/ https://ncbi.nlm.nih.gov/pubmed/21927649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn2000266 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|